Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2019-08-07 Regulatory Filings
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of the effective date of a Registration Statement on Form S-1. It references securities regulations and rules under the Securities Act of 1933 and the Securities Exchange Act of 1934. The content is related to the registration and offering process of securities, specifically the acceleration request for a registration statement effectiveness. It does not contain financial statements, earnings data, management discussion, or other report content. It is a regulatory filing related to securities registration and compliance, not a financial report or announcement of results. The document length is short (1828 characters), and it is a formal correspondence with the SEC, fitting the Regulatory Filings (RNS) category as a general regulatory announcement and compliance document.
2019-08-07 English
AMENDMENT NO. 4 TO FORM S-1
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 4 to Form S-1 Registration Statement filed with the SEC, dated August 6, 2019. It includes detailed information about the securities offering, including the types of shares, offering price, underwriting arrangements, and other related disclosures. Form S-1 is a registration statement used for initial public offerings or other securities offerings to register securities with the SEC. This document is not an annual report, earnings release, or any other financial report but a capital raising filing. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, not just an announcement or a brief notice, confirming it is a substantive filing related to capital raising.
2019-08-06 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 6, 2019, reporting the entry into a material definitive agreement involving conversion of debt to shares. It details the conversion agreement terms and references exhibits. The document is a current report on a specific event, not a full financial report or earnings release. It is not an announcement of a report publication but the actual filing of the event. The content fits the category of Capital/Financing Update (CAP) as it involves conversion of debt to equity, a financing activity affecting capital structure.
2019-08-06 English
CURRENT REPORT
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated August 1, 2019, reporting the entry into a material definitive agreement involving convertible promissory notes and securities purchase agreements. It details financing activities including issuance of convertible notes and receipt of proceeds from investors. The document does not contain full financial statements or comprehensive financial performance data but focuses on capital raising and financing transactions. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 5147 characters, sufficient to contain substantive details about the financing event rather than just an announcement or reference to a report. Hence, the classification is CAP with high confidence.
2019-08-01 English
AMENDMENT NO.1 TO FORM 8-K
Regulatory Filings Classification · 95% confidence The document is an Amendment No.1 to Form 8-K, which is a current report filed with the SEC to disclose material events. The text describes an amendment clarifying the issuance of shares under a Stock Purchase Agreement. It is not a full financial report, earnings release, or management discussion. The document is short (3300 characters) and serves as an update to a previously filed 8-K. This fits the category of a Regulatory Filing (RNS), which covers miscellaneous SEC filings that do not fit other specific categories.
2019-07-24 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC Division of Corporate Finance regarding comments on Amendment No. 2 to a Registration Statement on Form S-1. It contains responses to SEC staff comments and mentions submission of Amendment No. 3 to the registration statement. The content is related to regulatory correspondence about a registration statement for securities offering, not a financial report or earnings release. The document is relatively short (2778 characters) and is a formal response letter rather than a report or announcement of voting results or management changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory correspondence and filings that do not fit other specific categories.
2019-07-24 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.